The Class Action Saga
NEW YORK, Oct. 23, 2024 /PRNewswire/ — The legal storm clouds are gathering over Metagenomi, Inc. with a securities class action lawsuit snowballing in the United States District Court for the Northern District of California. The lawsuit is on behalf of individuals and entities that dabbled in Metagenomi, Inc. (“Metagenomi” or the “Company”) MGX securities between February 6, 2024, and September 26, 2024, collectively deemed the “Class Period.”
All investors facing losses are given the clarion call to reach out to the firm swiftly at classmember@whafh.com or through (800) 575-0735 or (212) 545-4774 for guidance. Further data regarding the lawsuit or the opportunity to join the case can be sourced from their website, www.whafh.com.
The Tumultuous Journey
The fateful February 9, 2024 witnessed Metagenomi spawning its initial public offering (IPO), pitching 6.25 million shares of common stock at $15.00 per share.
However, the dice rolled differently on May 1, 2024, when Metagenomi and Moderna, Inc. decided to part ways on primary hyperoxaluria type 1 (PH1). The termination deal stipulated that Metagenomi would reclaim the developmental rights for the PH1 program.
In a market swirl, the news sent Metagenomi’s stock plummeting by $0.87 per share, a crushing 12.36% nosedive, reaching a closing mark of $6.17 per share on May 2, 2024.
The Legal Guardians of the Arena
Guiding the legal battle is Wolf Haldenstein, showcasing prowess in spearheading securities class actions and derivative litigations across state and federal domains. The firm’s footprint spans various practice zones, with outposts in New York, Chicago, Nashville, and San Diego. Courts have regularly entrusted the firm with crucial roles in intricate securities multi-district and consolidated litigations, validating the caliber of their expertise.
Should any queries or deliberations on the case arise, investors are urged to promptly engage with Wolf Haldenstein through (800) 575-0735 or via email at classmember@whafh.com.
Contact:
Wolf Haldenstein Adler Freeman & Herz LLP, led by Gregory Stone, the Director of Case and Financial Analysis, through gstone@whafh.com or classmember@whafh.com, or by dialing (800) 575-0735 or (212) 545-4774.
It’s noteworthy that certain jurisdictions might regard this press release as Attorney Advertising, as per the prevailing law and ethical norms.
